Prospect Capital Corporation files regulatory reports that document its business development company structure, investment results, distribution policy and capital structure. Form 8-K filings cover quarterly results releases, Regulation FD distribution announcements, material agreements and financing activity involving common stock, preferred stock series and senior unsecured notes.
Proxy statements and shareholder-meeting filings describe voting matters for common and preferred stockholders, governance procedures and meeting mechanics. Prospect Capital filings also document preferred stock offering arrangements, dealer manager agreements, equity distribution agreements, dividend declarations and the security terms associated with its debt and preferred equity instruments.
Prospect Capital Corporation is offering three series of Prospect Capital InterNotes®: 7.250% due 2029, 7.500% due 2031 and 7.750% due 2033. Each series is callable at 100.000% on or after 11/15/2026. Trade date is May 18, 2026 with settlement on May 21, 2026. Notes issue in denominations of $1,000, pay semi-annual interest commencing 11/15/2026, and accrue interest from May 21, 2026. The offering is being made under an existing shelf program that authorizes up to $1.0 billion of InterNotes; as of February 6, 2026 approximately $637.2 million aggregate principal amount of notes were outstanding. Company context: total assets ~$6.5 billion and portfolio fair value ~$6.4 billion as of December 31, 2025; NAV per share was $6.21 as of December 31, 2025.
Prospect Capital Corporation entered an equity distribution agreement allowing it to issue and sell up to $400,000,000 aggregate liquidation preference of its 5.35% Series A Fixed Rate Cumulative Perpetual Preferred Stock through A.G.P. / Alliance Global Partners and other sales agents in at-the-market transactions.
The sales agents may earn up to 2.0% of the gross sales price as commissions. To support the preferred issuance, Prospect Capital reclassified 16,000,000 authorized but unissued common shares into Series A Preferred Stock, reducing authorized common stock from 1,248,117,104 shares to 1,232,117,104 shares.
Prospect Capital Corporation has filed a prospectus supplement establishing an at-the-market offering to sell up to $400,000,000 aggregate liquidation preference of its 5.35% Series A Fixed Rate Cumulative Perpetual Preferred Stock. The Series A carries a $25.00 liquidation preference per share and a fixed annual dividend rate of 5.35% ($1.3375 per share per year). The prospectus supplement states the Series A is listed on the NYSE under "PSEC PRA" and shows 5,251,157 shares of Series A Preferred Stock outstanding as of the date of the prospectus supplement. The company may sell shares through an equity distribution agreement with A.G.P. as sales agent, using ordinary brokers’ transactions that qualify as an at-the-market offering. Net proceeds, if the full $400,000,000 liquidation preference were sold at the last reported price of $18.24 per share, are estimated at approximately $284.8 million after estimated expenses and commissions. The prospectus supplement includes customary risk factors, conversion and special redemption rights on a Change of Control Triggering Event, and incorporation by reference of the company’s SEC reports.
Prospect Capital Corporation reported net investment income of $78.5 million, or $0.16 per common share, for the quarter ended March 31, 2026, with net income applicable to common shareholders of $26.4 million, or $0.05 per share. Net asset value per common share was $6.05, compared with $6.21 at the prior quarter end. The company declared monthly common dividends of $0.035 per share for May through August 2026, and detailed scheduled cash dividends on multiple preferred share classes based on stated annual rates between 5.35% and 7.50%. Prospect highlighted a predominantly first lien, senior secured middle-market lending portfolio, low non-accruals at 0.7% of total assets at fair value, and strong balance sheet metrics including a net-of-cash debt to total assets ratio of 27.0% and balance sheet cash plus undrawn revolver capacity of $1.75 billion.
Prospect Capital Corporation reported a net increase in net assets from operations of $56.5 million for the quarter ended March 31, 2026, compared with a loss of $139.9 million a year earlier. Basic and diluted earnings per common share were $0.05 versus a loss of $0.39.
Total investment income was $150.1 million, down from $170.7 million, as interest income from non‑control investments and structured credit securities declined. Net investment income was $78.5 million, slightly lower than $83.5 million in the prior‑year quarter, reflecting reduced operating expenses after reimbursement of administration costs.
At March 31, 2026, investments at fair value totaled $6.30 billion versus $6.67 billion on June 30, 2025. Net assets applicable to common shares were $3.0 billion, with Net Asset Value Per Common Share of $6.05, down from $6.56. The company continued to finance itself through a revolving credit facility, public notes and Prospect Capital InterNotes®.
Prospect Capital Corporation filed Post-Effective Amendment No. 12 to its Form N-2 to add exhibits. The filing, made under Rule 462(d), is "solely for the purpose of filing exhibits to the Registration Statement" and "shall become effective immediately upon filing." The amendment incorporates historical financial statements and a large set of supplemental indentures and notes dated from 2012 through 2024.
Prospect Capital Corporation priced three Prospect Capital InterNotes® series. The pricing supplement lists a 7.250% note due 5/15/2029 with principal $55,000, a 7.500% note due 5/15/2031 with principal $17,000, and a 7.750% note due 5/15/2033 showing no principal in the excerpt. The notes accrue interest from May 7, 2026, pay semi-annually on May 15 and November 15, and are callable at 100.000% beginning 11/15/2026.
Trade date was May 4, 2026 with settlement on May 7, 2026. Selling price for the two stated series is 100.000% with gross concessions shown; net proceeds figures are provided for the two small-amount series. The offering is under the company’s InterNotes® medium-term note program and supplements the February 10, 2026 prospectus and prospectus supplement.
Prospect Capital Corporation filed Post‑Effective Amendment No. 11 to its Form N‑2 (Registration No. 333-293349) to furnish exhibits and incorporate financial statements and schedules. The amendment lists consolidated financial statements as of June 30, 2022 and interim statements as of December 31, 2022, and attaches numerous supplemental indentures and note forms.
Prospect Capital Corporation priced three series of Prospect Capital InterNotes®: $101,000 of 7.000% Notes due 4/15/2029, $45,000 of 7.250% Notes due 4/15/2031, and $55,000 of 7.500% Notes due 4/15/2033. The Notes accrue interest from 4/30/2026, pay semi‑annually commencing 10/15/2026, and are callable at 100.000% on or after 10/15/2026.
The pricing supplement shows selling prices at 100.000% with specified gross concessions and net proceeds per series, issuance under the February 16, 2012 indenture as supplemented, and customary redemption, survivor’s option and SOFR-transition provisions. The offering is pursuant to the prospectus dated 2/10/2026.
Prospect Capital Corporation priced a preliminary offering of three series of Prospect Capital InterNotes®: 7.250% Notes due 2029, 7.500% Notes due 2031 and 7.750% Notes due 2033. Each series is fixed-rate, semi-annual, callable at 100.000% on 11/15/2026 and thereafter. Trade date is May 4, 2026 with settlement on May 7, 2026. Minimum denominations are $1,000 and notes will be issued in DTC book-entry form under the February 16, 2012 indenture as supplemented May 7, 2026. The supplement references an available program capacity of $1.0 billion authorized by the board and states approximately $637.2 million aggregate principal amount of notes outstanding as of February 6, 2026. Additional corporate context: NAV per share was $6.21 as of December 31, 2025 and total assets were approximately $6.5 billion as of December 31, 2025.